Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

12 results
Display

History and future of hepatitis B virus control in South Korea

Kim DY

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Can hepatocellular carcinoma recurrence be prevented after liver transplantation?

Kim JM

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Microwave thermosphere versus radiofrequency ablation for hepatocellular carcinoma: Are we approaching the time to end the debate?

Kim MD

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline

Cho JY, Lee YS, Kim SS, Song DS, Lee JH, Kim JH, on behalf of the Korean Association for the Study of the Liver

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Impact of branched-chain amino acids and frailty on the management of lenvatinib-related fatigue in patients with hepatocellular carcinoma

Shimose S, Koya S, Kawaguchi T, Hirota K, Yoshio S, Niizeki T, Matsuse H, Torimura T

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis

Chun HS, Choe AR, Lee M, Cho Y, Kim HY, Yoo K, Kim TH

Although patients with cirrhosis are known to be in a state of “rebalance” in that pro- and anticoagulant factors increase the risk for both bleeding and thrombosis, the prevalence of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent advances in nonalcoholic fatty liver disease metabolomics

Kim HY

The clinical phenotypes of nonalcoholic fatty liver disease (NAFLD) encompass from simple steatosis to nonalcoholic steatohepatitis (NASH) with varying degrees of fibrosis or cirrhosis. Liver biopsy has been the standard...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
New next-generation microwave thermosphere ablation for small hepatocellular carcinoma

Tamai H, Okamura J

Background/Aims: In July 2017, the Emprint™ next-generation microwave ablation system using thermosphere technology (Covidien, Boulder, CO, USA) was approved for use in Japan. This system can produce a predictable spherical...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma

Wu JW, Kao JH, Tseng TC

Patients with chronic hepatitis B virus (HBV) infection are at risk of developing hepatocellular carcinoma (HCC), and serum markers reflecting viral replication are potential predictors for HCC development. Besides the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis

Liu CH, Chen CY, Su WW, Liu CJ, Lo CC, Huang KJ, Chen JJ, Tseng KC, Chang CY, Peng CY, Shih YL, Huang CS, Kao WY, Yang SS, Tsai MC, Wu JH, Chen PY, Su PY, Hwang JJ, Fang YJ, Lee PL, Tseng CW, Lee FJ, Lai HC, Hsieh TY, Chang CC, Chang CH, Huang YJ, Kao JH

Background/Aims: Real-world studies assessing the effectiveness and safety of sofosbuvir/velpatasvir (SOF/VEL) plus ribavirin (RBV) for Child-Pugh B/C hepatitis C virus (HCV)-related cirrhosis are limited. Methods: We included 107 patients with Child-Pugh...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma

Kang I, Lee JG, Choi SH, Kim HJ, Han DH, Choi GH, Kim MS, Choi JS, Kim SI, Joo DJ

Background/Aims: This study aimed to investigate whether everolimus (EVR) affects long-term survival after liver transplantation (LT) in patients with hepatocellular carcinoma (HCC). Methods: The data from 303 consecutive patients with HCC...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea

Kim KD, Lee JE, Kim JM, Lee O, Hwang NY, Rhu J, Choi GS, Kim K, Joh JW

Background/Aims: Hepatitis B core antibody (anti-HBc)-positive donors are used as an extended donor pool, and current guidelines recommend the usage of nucleos(t)ide analogues (NAs) as prophylaxis for preventing de novo...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr